Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial.

Int J Nephrol Renovasc Dis · 2018 · PMC5774473 · PMID 29391823

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

close to being statistically significantP =0.054so close (0.05 < p ≤ 0.1)

However, higher proportion of patients in the pulse group (39.2%) had 30% or more reduction in PTH during the study than the daily group (26.4%), which is close to being statistically significant (χ 2 (1) =3.7, P =0.054).

also in 228 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.